Pour une meilleure utilisation, nous vous conseillons d’activer Javascript dans votre navigateur.

Ret Proto-Oncogene anticorps (AA 1-1072)

RET Reactivité: Humain WB Hôte: Souris Polyclonal unconjugated

N° du produit ABIN2350379

Fiche de données

Antigène Voir toutes Ret Proto-Oncogene (RET) Anticorps

Ret Proto-Oncogene (RET)
Épitope
27

21

15

15

15

11

9

9

8

8

8

7

6

6

4

4

3

3

2

2

2

2

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1
AA 1-1072
Reactivité
161

100

81

5

3

2

2

2

2

1

1

1

1

1

1
Humain
Hôte
185

21

2

1

1

1
Souris
Anticorps secondaires appropriés
Clonalité
180

31
Polyclonal
Conjugué
88

14

10

9

9

9

9

9

9

9

6

5

5

5

5

5

4

1
Cet anticorp Ret Proto-Oncogene est non-conjugé
Application
169

82

66

65

42

28

17

15

15

9

4

3

2

1

1

1

1

1

1
Western Blotting (WB)

Réactivité croisée

Humain

Réactivité croisée (Details)

Calculated cross reactivity: Hu

Attributs du produit

RET (CDHF12, CDHR16, PTC, RET51, Proto-oncogene Tyrosine-protein Kinase Receptor Ret, Cadherin Family Member 12, Proto-oncogene c-Ret, Soluble RET Kinase Fragment, Extracellular Cell-membrane Anchored RET Cadherin 120kD Fragment)

Purification

Purified by Protein A affinity chromatography.

Immunogène

Full length human RET, aa1-1072 (AAH04257.1).

Isotype

IgG

Top Product

Discover our top product RET Anticorps primaire
anti-Ret Proto-Oncogene (RET) (AA 702-848) antibody
RET Reactivité: Humain IHC, StM Hôte: Souris Monoclonal RET-2795 unconjugated

anti-Ret Proto-Oncogene (RET) (AA 1-1072) antibody
RET Reactivité: Humain WB, PLA Hôte: Lapin Polyclonal unconjugated

anti-Ret Proto-Oncogene (RET) (AA 702-848) antibody
RET Reactivité: Humain ELISA, Coat Hôte: Souris Monoclonal RET-2663 unconjugated

anti-Ret Proto-Oncogene (RET) antibody
RET Reactivité: Humain WB Hôte: Lapin Monoclonal unconjugated

anti-Ret Proto-Oncogene (RET) (AA 152-182), (N-Term) antibody
RET Reactivité: Humain WB, IHC (p) Hôte: Lapin Polyclonal RB00705 unconjugated

anti-Ret Proto-Oncogene (RET) (AA 1012-1042), (C-Term) antibody
RET Reactivité: Humain WB, IHC (p) Hôte: Lapin Polyclonal RB01561 unconjugated

anti-Ret Proto-Oncogene (RET) (AA 361-458) antibody
RET Reactivité: Humain WB, ELISA, PLA Hôte: Souris Monoclonal 1A5 unconjugated

anti-Ret Proto-Oncogene (RET) (C-Term) antibody
RET Reactivité: Humain, Souris, Rat WB, ELISA, IF, ICC Hôte: Lapin Polyclonal unconjugated

anti-Ret Proto-Oncogene (RET) (pTyr1062) antibody
RET Reactivité: Humain, Souris, Rat WB, ELISA, IF, ICC Hôte: Lapin Polyclonal unconjugated

anti-Ret Proto-Oncogene (RET) (AA 29-300) antibody
RET Reactivité: Humain WB, IHC, IF Hôte: Lapin Polyclonal unconjugated

Indications d'application

Optimal working conditions should be determined by the investigator.

Restrictions

For Research Use only
Format

Liquid

Buffer

Supplied as a liquid in PBS, pH 7.2.

Stock

-20 °C

Stockage commentaire

-20°C
Antigène

Ret Proto-Oncogene (RET)

Autre désignation

RET (RET Produits)

Synonymes

anticorps c-ret, anticorps cret, anticorps etID315074.13, anticorps ret1, anticorps wu:fd13h01, anticorps X-ret, anticorps ret-A, anticorps xret, anticorps RET, anticorps MTC1, anticorps CDHF12, anticorps CDHR16, anticorps HSCR1, anticorps MEN2A, anticorps MEN2B, anticorps PTC, anticorps RET-ELE1, anticorps RET51, anticorps RET9, anticorps c-Ret, anticorps ret proto-oncogene receptor tyrosine kinase, anticorps ret proto-oncogene S homeolog, anticorps ret proto-oncogene, anticorps ret, anticorps ret.S, anticorps RET, anticorps Ret

Pathways

Signalisation RTK, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation